Exabis Library
Welcome to the e-CCO Library!
P735 Comparative assessment of probiotics and standard therapies for mild to moderate ulcerative colitis: A systematic review and network meta-analysis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P735: Immunogenicity differences between anti-TNF drugs
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P735: Incidence of venous thromboembolic complications in controlled trials of inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P735: Indirect burden of patients with moderate inflammatory bowel disease in Uppsala County Council, Sweden: a retrospective study using real-world data
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P735: Real-life experience with the use of Tofacitinib in Colombian patients with moderate to severe Ulcerative Colitis: a descriptive study.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P736 Utility of infliximab serum concentration in inflammatory bowel disease treatment in real world practice at Hospital Universitario de Canarias
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P736: Characteristics of polymeric formula and mode of delivery of exclusive enteral nutrition have no effect on disease outcome and weight gain in children with Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P736: Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P736: Point-of-care infliximab quantification in inflammatory bowel disease in daily practice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P736: Psychological impact of inflammatory bowel disease: differences by gender and age. The ENMENTE Project
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P737 Ustekinumab induction effectiveness in Crohn’s disease in a real-life cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P737: Early life microbial exposure, lifestyle and comorbidity as risk factors for microscopic colitis: a case-control study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P737: Intensification with intravenous ustekinumab in refractory Crohn´s disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P737: SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P737: The use of infliximab therapeutic drug monitoring in virtual biologics clinic for inflammatory bowel disease (IBD) leads to clinically durable results
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P738 Real world outcomes on the efficacy and safety of combination of biologic and immunosuppressive therapy in liver transplant recipients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P738: Assessing aCCess to investigations in IBD (ACCID) – results from an international inflammatory bowel disease survey
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P738: Surgery for Crohn's Disease: Results from a Spanish cohort with 15 years of follow-up
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P738: Sustained clinical remission with vedolizumab in Moderate-to-Severe Crohn’s disease: A GEMINI 2 post hoc analysis of Week 14 remitters
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P738: The budget impact of early dose optimisation with golimumab in ulcerative colitis in the UK
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM